Found a bug or want a feature? Verified reports earn free credits.
Log inSign up
Back to alerts
ASTRAZENBSEASTRAZENECA PHARMA IND LT· PharmaceuticalsMediumNeutral
Announced Fri, 16 Oct, 2026 · 18:57 IST

Postal Ballot Results: New Director Appointed, Another Reassigned

Management Changes View source PDFExplain this filing

ASTRAZEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.4%Reaction day
₹5932.00
prior close
₹5960.00
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.7%+4.1% vs market
Pharmaceuticals peers, median of 172sector-1.6%+4.0% vs sector

On the reaction day the stock moved 4.1 pts more than Nifty Microcap 250 and 4.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.3
10m
-0.5
15m
-0.9
30m
-0.9
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.4-1.7+4.1-1.6+4.0
Next day
+2.2-4.2+6.5-3.5+5.7
2d
+1.5-5.2+6.7-3.8+5.3
3d
+1.3-7.4+8.7-5.3+6.6
4d
+2.0-7.0+9.0-4.1+6.1
5d
+2.9pendingpending-2.4+5.3
1w
—————
15d
—————
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 172Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

AstraZeneca Pharma India announced postal ballot results on October 16, 2026. Two ordinary resolutions passed with near-unanimous support. Resolution 1 approved appointment of Mr. Arun Krishna (DIN: 11876664) as Non-Executive Director with 99.97% votes in favour. Resolution 2 changed designation of Ms. Bhavana Agrawal from Executive Director to Non-Executive Director with 99.99% in favour. Promoters voted 100% on both. Overall, 84.5% of outstanding shares participated in e-voting.

Likely market impact

New Non-Executive Director joins the board. Bhavana Agrawal exits executive role, indicating internal board reshuffle with no immediate operational impact.